HealthDay News — Patients are more likely to have positive bronchodilator responsiveness in the morning and in winter months, according to a study published online March 11 in Thorax. Ben Knox ...

Notably, the likelihood for bronchodilator responsiveness per the 2005 definition significantly went down with testing in autumn vs. winter (aOR = 0.67; 95% CI, 0.48-0.92), according to the study.

Even with bronchodilator and steroid treatment, many people with COPD continue to have symptom flare-ups. "For some of these patients, treatment with a biologic may offer a promising option ...

"Little Evidence Behind Bronchodilator Therapy For Cystic Fibrosis." ScienceDaily. ScienceDaily, 26 October 2005. <www.sciencedaily.com / releases / 2005 / 10 / 051026085739.htm>.

Combined treatment with bronchodilator drugs and steroids resulted in a mean increase in vital capacity and first-second volume of almost 50 per cent of the pretreatment value.

PEF failed to consistently reflect FEV1 improvements after bronchodilation, indicating that handheld spirometry may better ...

Bronchodilator responsiveness over 20% was linked to exacerbations and decreased prebronchodilator FEV 1. More patients in this group vs. the low responsiveness group used high-dose inhaled ...

Lipari M, Pramodini KPB, Wilhelm SM. Dual-versus mono-bronchodilator therapy in moderate to severe COPD [published online June 4, 2020]. Annals of Pharmacotherapy. doi: 10.1177/1060028020932134.

Cite this: Unpredictability of Deception in Compliance With Physician-Prescribed Bronchodilator Inhaler Use in a Clinical Trial - Medscape - Aug 01, 2000.

Conclusions Inhaled dual bronchodilator therapy did not decrease respiratory symptoms in symptomatic, tobacco-exposed persons with preserved lung function as assessed by spirometry.

Each patient's bronchodilator responsiveness (BDR) was determined by three measures: absolute change in the volume of air exhaled during a forced breath in one second (FEV1) (BDRABS); change as ...